Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Gronchi, Alessandro, Dr, Ferrari, Stefano, MD, Quagliuolo, Vittorio, MD, Broto, Javier Martin, MD, Pousa, Antonio Lopez, MD, Grignani, Giovanni, MD, Basso, Umberto, MD, Blay, Jean-Yves, Prof, Tendero, Oscar, MD, Beveridge, Robert Diaz, MD, Ferraresi, Virginia, MD, Lugowska, Iwona, MD, Merlo, Domenico Franco, MD, Fontana, Valeria, MSc, Marchesi, Emanuela, MSc, Donati, Davide Maria, MD, Palassini, Elena, MD, Palmerini, Emanuela, MD, De Sanctis, Rita, MD, Morosi, Carlo, MD, Stacchiotti, Silvia, MD, Bagué, Silvia, MD, Coindre, Jean Michelle, Prof, Dei Tos, Angelo Paolo, Prof, Picci, Piero, MD, Bruzzi, Paolo, MD, Casali, Paolo Giovanni, MD
Published in The lancet oncology (01.06.2017)
Published in The lancet oncology (01.06.2017)
Get full text
Journal Article